Clinical Trial: A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia

U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07304089) titled 'A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia' on Dec. 22.

Brief Summary: Stride Dystonia is a randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of VIM0423 in individuals with isolated dystonia.

The main objectives of this clinical trial are to determine the following:

* Does VIM0423 therapy improve dystonia symptoms compared to placebo?

* Is VIM0423 well tolerated in individuals with isolated dystonia? and

* Do the therapeutic effects of VIM0423 confer improvements on daily function and quality of life?

Study Start...